2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Sarcoma
2
Radiation Injuries
2
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Lymphedema
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Laryngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Flap Necrosis
1
Fibrosis
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Blood Specimen Collection
8
Magnetic Resonance Spectroscopy
5
Pentoxifylline
4
Liver Transplantation
4
Tenofovir
3
Specimen Handling
3
High-Energy Shock Waves
3
Tocopherols
2
Sorafenib
2
Simvastatin
2
Low-Level Light Therapy
2
Gemcitabine
2
tremelimumab
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
ruxolitinib
1
peginterferon alfa-2a
1
navitoclax
1
maltodextrin
1
hepatitis B hyperimmune globulin
1
esmolol
1
epigallocatechin gallate
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
atezolizumab
1
apixaban
1
alpha-Tocopherol
1
adefovir dipivoxil
1
Viusid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
Hyperbaric Oxygenation
×
Clear all
NCT01822405
2013-04-02
ORT-OXI-2009
Hospital Universitario de Canarias
Phase 2
Unknown
42 enrolled